Linvoseltamab
Regeneron
['mmsm']
aa16: infection rate, all grades: 60%, g3/4: 37%. pna g3/4:14%, opportunistic infxn: 6% #mmsm #myeloma #medtwitter #meded #asco23 #usmirc 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter